Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
$1.44
$1.49
$1.31
▼
$8.34
$7.59M-2.03207,251 shs69,740 shs
OPTH
Optimi Health
$4.93
$4.73
$4.00
▼
$6.40
$28.23MN/A23,971 shs10,656 shs
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
$3.89
$3.60
$3.07
▼
$10.00
$29.11M1.45127,006 shs182,077 shs
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$4.90
$5.08
$2.00
▼
$17.96
$24.60M1.521.50 million shs18,007 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
0.00%-2.04%0.00%-25.39%-68.83%
OPTH
Optimi Health
0.00%-1.40%+1.65%-12.59%+492,999,900.00%
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
0.00%+0.78%+18.24%-7.60%-33.16%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00%-7.55%+55.06%+45.40%+38.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
$1.44
$1.49
$1.31
▼
$8.34
$7.59M-2.03207,251 shs69,740 shs
OPTH
Optimi Health
$4.93
$4.73
$4.00
▼
$6.40
$28.23MN/A23,971 shs10,656 shs
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
$3.89
$3.60
$3.07
▼
$10.00
$29.11M1.45127,006 shs182,077 shs
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$4.90
$5.08
$2.00
▼
$17.96
$24.60M1.521.50 million shs18,007 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
0.00%-2.04%0.00%-25.39%-68.83%
OPTH
Optimi Health
0.00%-1.40%+1.65%-12.59%+492,999,900.00%
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
0.00%+0.78%+18.24%-7.60%-33.16%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00%-7.55%+55.06%+45.40%+38.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
2.00
Hold$31.002,052.78% Upside
OPTH
Optimi Health
1.50
ReduceN/AN/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
1.00
SellN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ACXP, TAOX, OPTH, and UPC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
OPTH
Optimi Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/14/2026
OPTH
Optimi Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/29/2026
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/17/2026
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/14/2026
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/29/2026
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 8/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
N/AN/AN/AN/A$2.07 per shareN/A
OPTH
Optimi Health
$175.67K160.69N/AN/AN/A∞
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
$772.50K37.68N/AN/A$2.83 per share1.37
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$17.86M1.38N/AN/A$99.64 per share0.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
-$7.97M-$2.69N/AN/AN/AN/A-124.73%-87.48%11/11/2026 (Estimated)
OPTH
Optimi Health
-$1.12M-$0.76N/AN/AN/AN/AN/AN/AN/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
-$28.74M-$3.85N/AN/AN/A-2,153.97%-128.51%-97.54%N/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
-$3.67MN/AN/AN/AN/AN/AN/AN/AN/A

Latest ACXP, TAOX, OPTH, and UPC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
-$0.3767-$0.53-$0.1533-$0.53N/AN/A
8/13/2026Q2 2026
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
N/A-$1.83N/A-$1.83N/A$0.09 million
7/29/2026Q2 2026
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/A-$1.38N/A-$1.38N/A$4.52 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
N/AN/AN/AN/AN/A
OPTH
Optimi Health
N/AN/AN/AN/AN/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
N/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
N/A
3.88
3.88
OPTH
Optimi Health
0.04
0.06
0.03
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
N/A
19.98
19.98
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.04
4.05
3.90

Institutional Ownership

CompanyInstitutional Ownership
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
11.53%
OPTH
Optimi Health
N/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
10.34%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.18%

Insider Ownership

CompanyInsider Ownership
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
20.30%
OPTH
Optimi Health
N/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
2.70%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
57.38%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acurx Pharmaceuticals, Inc. stock logo
ACXP
Acurx Pharmaceuticals
35.27 million4.20 millionNo Data
OPTH
Optimi Health
N/A5.73 millionN/AN/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
47.48 million7.28 millionN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
2205.02 million2.14 millionN/A

Recent News About These Companies

Universe Pharmaceuticals (NASDAQ:UPC) Upgraded at Wall Street Zen
August 29 at 1:24 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30989219
Universe Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:UPC
July 18, 2026  |  benzinga.comhttps://www.benzinga.com/quote/UPC/earnings
Universe Pharmaceuticals INC - Ordinary Shares - Class A
July 17, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/upc-universe-pharmaceuticals-inc-ordinary-shares-class-a
Universe Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:UPC | Benzinga
June 29, 2026  |  benzinga.comhttps://www.benzinga.com/quote/UPC/analyst-ratings
4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones
June 29, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/4-sizzling-biotech-and-healthcare-companies-reporting-strategic-milestones-1036282767
China's Universe Pharmaceuticals (NASDAQ: UPC) Makes Nasdaq Top Gainer List on Acquisition News
June 29, 2026  |  investorideas.comI
Universe Pharmaceuticals INC.: Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-06/68880740-universe-pharmaceuticals-inc-universe-pharmaceuticals-inc-announces-strategic-acquisition-to-expand-pharmaceutical-patent-portfolio-399.htm
Universe Pharmaceuticals Inc
June 26, 2026  |  fool.comhttps://www.fool.com/quote/nasdaq/upc/
UPC stock surges 288% after hours — what’s driving the rally?
June 26, 2026  |  msn.comhttps://www.msn.com/en-in/money/general/upc-stock-surges-288-after-hours-what-s-driving-the-rally/ar-AA26Dply
Universe Pharmaceuticals to acquire Best Praise for $10.75M
June 26, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4607850-universe-pharmaceuticals-to-acquire-best-praise-for-1075m
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/26/3318447/0/en/universe-pharmaceuticals-inc-announces-strategic-acquisition-to-expand-pharmaceutical-patent-portfolio.html
Universe Pharmaceuticals Stock News
June 17, 2026  |  benzinga.comhttps://www.benzinga.com/quote/UPC/news
Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology
June 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260616139888/en/hologic-secures-significant-patent-victory-against-siemens-over-breast-cancer-detection-technology/
Universe Pharmaceuticals Incorporation Class A
April 29, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/UPC
Universe Pharmaceuticals (NASDAQ:UPC) Stock Price Down 2.4% – Time to Sell?
April 25, 2026  |  defenseworld.netD
Universe Pharmaceuticals Sets February 13 Effective Date for Dual-Class Share Structure
February 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/universe-pharmaceuticals-sets-february-13-effective-date-for-dual-class-share-structure?utm_source=marketbeat.com&utm_medium=referral
Universe Pharmaceuticals INC Implements Dual-Class Share Structure on Nasdaq Effective February 13, 2026
February 11, 2026  |  quiverquant.comQ
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
February 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/11/3236664/0/en/Universe-Pharmaceuticals-INC-Announces-Effective-Date-of-Dual-Class-Share-Structure.html
Universe Pharmaceuticals Inc trading resumes
October 8, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/universe-pharmaceuticals-inc-trading-resumes/ar-AA1O66lQ
Universe Pharmaceuticals Inc trading halted, volatility trading pause
October 8, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/universe-pharmaceuticals-inc-trading-halted-volatility-trading-pause/ar-AA1O5To9

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
Jersey Mike's Subs logo above a sandwich on a wooden counter with tomatoes, lettuce, oil, and seasoning.
Jersey Mike's Serves Fresh Gains After IPO Stumble
By Jeffrey Neal Johnson | August 4, 2026
Acurx Pharmaceuticals stock logo

Acurx Pharmaceuticals NASDAQ:ACXP

$1.44 0.00 (0.00%)
Closing price 08/28/2026 04:00 PM Eastern
Extended Trading
$1.45 +0.01 (+0.90%)
As of 04:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Optimi Health NASDAQ:OPTH

$4.93 0.00 (0.00%)
As of 08/28/2026 03:59 PM Eastern

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.

Synaptogenix stock logo

Synaptogenix NASDAQ:TAOX

$3.89 0.00 (0.00%)
Closing price 08/28/2026 04:00 PM Eastern
Extended Trading
$3.90 +0.01 (+0.26%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.

Universe Pharmaceuticals stock logo

Universe Pharmaceuticals NASDAQ:UPC

$4.90 0.00 (0.00%)
Closing price 08/28/2026 03:59 PM Eastern
Extended Trading
$4.65 -0.25 (-5.08%)
As of 04:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas